Arthur S. Przybyl

Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL.

ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come!

International Medication Systems Ltd. engages in manufacturing pharmaceutical products. The company is headquartered in Cucamonga,CA.

Bioject, Inc. supplies surgical equipment. The private company is based in Tualatin, OR.

Part of Bioventus, Inc., Hearing Innovations, Inc. is a medical device and regenerative tissue product company that provides minimally invasive therapeutic ultrasonic medical devices. Hearing Innovations was acquired by Bioventus in 2021 and is based in Tucson, AZ. The company offers a complete portfolio of OrthoPlastic Clinical Solutions for surgical wounds and slow-healing or chronic wounds, such as diabetic foot ulcers and venous leg ulcers. Additionally, the company provides webinars and podcasts for industry experts to learn about the latest medical breakthroughs.